Q4 2025 Management View CEO Timothy Herbert reported that the key challenge for the business is the coding of the Inspire V ...
MINNEAPOLIS - Inspire Medical Systems, Inc. (NYSE:INSP) reported fourth quarter earnings that beat analyst expectations, but shares tumbled 8.7% as the company disclosed a coding clarification that ...
Inspire Medical Systems (NYSE:INSP) management focused much of its fourth-quarter and full-year 2025 earnings call on reimbursement and coding uncertainty tied to the company’s Inspire 5 system, while ...
Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata Skin Sciences, Inc. (“Strata”) and its Chief Executive ...
Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.2% year on year to $269.1 million. On the other ...
Heartflow Inc. reports fourth-quarter results Thursday, with investors watching whether recent insurance coverage expansions and new reimbursement codes can accelerate adoption of the medical AI ...
Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results